HCAL
REGN icon

HURRICANE CAPITAL ADVISORS LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$483K Buy
775
+160
+26% +$109K 0.12% 173
2026
Q1 		$475K Buy
+615
New +$471K 0.15% 121
2024
Q4 		– Sell
-269
Closed -$283K – 673
2024
Q3 		$283K Buy
269
+250
+1,316% +$278K 0.1% 159
2024
Q2 		$20K Buy
+19
New +$18.4K 0.01% 442

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's REGN Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC increased its Regeneron Pharmaceuticals (REGN) stake by 26% in Q2 2026, buying an estimated $109K and bringing the position to 775 shares worth $483K. The position accounts for 0.12% of the portfolio, ranked #173.

HURRICANE CAPITAL ADVISORS LLC first reported a position in REGN in Q2 2024 and has held it in 4 quarters since. 1,345 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 775 shares of Regeneron Pharmaceuticals worth $483K as of Q2 2026.
  • HURRICANE CAPITAL ADVISORS LLC bought 160 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $109K.
  • Regeneron Pharmaceuticals made up 0.12% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #173 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • 1,345 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.